{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Synthetic Patient Data for Clinical Trials","description":"Sophie Furley in conversation with Dr. Boris Bogdan, Managing Director at Accenture and lead of Accenture's\u2019 center of excellence for precision oncology and personalized healthcare. The episode is focusing on \u201cSynthetic Patient Data for Clinical Trials\u201d one of the the most important topics in life sciences today. ","author_name":"Accenture partnerships","author_url":"https:\/\/www.bloomberg.com\/audio","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/21328811\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/111110\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/21328811"}